{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:51:41Z","timestamp":1776426701815,"version":"3.51.2"},"reference-count":198,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Since emerging in late 2019, coronavirus disease 2019 (COVID-19) has swiftly turned into a global public health emergency, exerting extensive influence on personal well-being and healthcare setups across the globe. In spite of the endeavors made by global health systems to tackle this issue, the COVID-19 pandemic has laid bare the weaknesses of these systems and spurred profound reflection on strategies for preventing and controlling novel viral diseases. This review focuses on how COVID-19 impacts cancer treatment and prognosis and delves into the virus\u2019s effect on the immune system, particularly immune cells and cytokines. Research indicates that a COVID-19 infection not only heightens the treatment complexity for cancer patients but also impacts their prognosis by interfering with the immune response mechanism. It leads to a decrease in the number and function of immune cells such as T cells, B cells, and natural killer cells (NK cells), which may weaken the antitumor immune response and promote tumor progression. Additionally, COVID-19 has triggered a cytokine storm, causing a massive release of inflammatory factors and further exacerbating immune system dysfunction. However, the review also identified potential benefits. For instance, COVID-19 vaccination may have initiated antitumor immune responses in humans, presenting novel avenues for cancer treatment. Additionally, investigating the mechanisms behind COVID-19 infection yields valuable knowledge that can guide the development of innovative antitumor therapies. In conclusion, COVID-19 has had a multifaceted and profound effect on cancer treatment and prognosis. By thoroughly investigating the virus\u2019s impact on the immune system and developing new antitumor treatments, we stand a better chance of addressing this challenge and improving cancer patients\u2019 survival rates and quality of life. However, due to time constraints, this study lacks long-term research data to better substantiate that COVID-19 can worsen the prognosis of cancer patients. Looking ahead, conducting long-term cohort studies and stratified research (based on cancer type, stage, etc.) can yield more valuable clinical data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004053","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T10:00:26Z","timestamp":1771581626000},"page":"7877-7896","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The impact of COVID-19 on the treatment and prognosis of cancer patients"],"prefix":"10.1097","volume":"112","author":[{"given":"Kaili","family":"Liao","sequence":"first","affiliation":[{"name":"Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Fu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuman","family":"Guo","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarong","family":"Wen","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Ai","sequence":"additional","affiliation":[{"name":"Queen Mary College, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Fu","sequence":"additional","affiliation":[{"name":"School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqian","family":"Liu","sequence":"additional","affiliation":[{"name":"Queen Mary College, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Hu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuowen","family":"Lu","sequence":"additional","affiliation":[{"name":"Queen Mary College, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqian","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwen","family":"Yan","sequence":"additional","affiliation":[{"name":"Queen Mary College, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Queen Mary College, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Cheng","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichen","family":"Jie","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Gan","sequence":"additional","affiliation":[{"name":"The Forth Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"R1-20260417","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN guideline","volume":"10","author":"Riaz A","year":"2025","journal-title":"Prem J Sci"},{"key":"R2-20260417","doi-asserted-by":"crossref","first-page":"e00228","DOI":"10.1128\/CMR.00228-20","article-title":"Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\/COVID-19 detection","volume":"34","author":"Safiabadi Tali","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"R3-20260417","doi-asserted-by":"crossref","first-page":"757\u201368","DOI":"10.1016\/S0140-6736(21)02346-1","article-title":"Diagnostics for COVID-19: moving from pandemic response to control","volume":"399","author":"Peeling","year":"2022","journal-title":"Lancet (London, England)"},{"key":"R5-20260417","doi-asserted-by":"crossref","first-page":"679\u201386","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"R6-20260417","doi-asserted-by":"crossref","first-page":"1255\u201356","DOI":"10.1002\/jmv.27491","article-title":"Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!","volume":"94","author":"Gao","year":"2022","journal-title":"J Med Virol"},{"key":"R7-20260417","doi-asserted-by":"crossref","first-page":"1825\u201332","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J Med Virol"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"5096\u2013102","DOI":"10.1002\/jmv.27990","article-title":"The deltacron conundrum: its origin and potential health risks","volume":"94","author":"Farheen","year":"2022","journal-title":"J Med Virol"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"199075","DOI":"10.1016\/j.virusres.2023.199075","article-title":"Future trajectory of SARS-CoV-2: constant spillover back and forth between humans and animals","volume":"328","author":"Cui","year":"2023","journal-title":"Virus Res"},{"key":"R10-20260417","doi-asserted-by":"crossref","first-page":"e29020","DOI":"10.1002\/jmv.29020","article-title":"The short and long-term impact of nonpharmaceutical interventions on the prevalence of varicella in Xi\u2019an during the COVID-19 pandemic","volume":"95","author":"Bai","year":"2023","journal-title":"J Med Virol"},{"key":"R11-20260417","doi-asserted-by":"crossref","first-page":"e2340","DOI":"10.1002\/rmv.2340","article-title":"SARS-CoV-2 and dengue virus co-infection: epidemiology, pathogenesis, diagnosis, treatment, and management","volume":"33","author":"Prapty","year":"2023","journal-title":"Rev Med Virol"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"3503\u201305","DOI":"10.1002\/jmv.27772","article-title":"Natural infections of SARS-CoV-2 increased in animals: how should humans interact with animals?","volume":"94","author":"Zhai","year":"2022","journal-title":"J Med Virol"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1016\/S2666-5247(22)00198-7","article-title":"Spillover infection of common animal coronaviruses to humans","volume":"3","author":"Zhai","year":"2022","journal-title":"Lancet Microbe"},{"key":"R14-20260417","doi-asserted-by":"crossref","first-page":"264\u201366","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R16-20260417","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/biomedicines10051002","article-title":"Exploring the utility of NK cells in COVID-19","volume":"10","author":"Deng","year":"2022","journal-title":"Biomedicines"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"101869","DOI":"10.1016\/j.tmaid.2020.101869","article-title":"Aerosol transmission of SARS-CoV-2: the unresolved paradox","volume":"37","author":"Priyanka","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"R18-20260417","doi-asserted-by":"crossref","first-page":"102694","DOI":"10.1016\/j.tmaid.2024.102694","article-title":"Zoonotic diseases in a changing climate scenario: revisiting the interplay between environmental variables and infectious disease dynamics","volume":"58","author":"Choudhary","year":"2024","journal-title":"Travel Med Infect Dis"},{"key":"R19-20260417","doi-asserted-by":"crossref","first-page":"396\u2013408","DOI":"10.4149\/av_2020_402","article-title":"Diagnosis of SARS-CoV-2: a review on the current scenario and future outlook","volume":"64","author":"Priyanka","year":"2020","journal-title":"Acta Virologica"},{"key":"R20-20260417","article-title":"Making sound public health policy decisions for COVID-19 vaccination: vaccine effectiveness, safety, affordability, programmatic logistics and roll-out globally","author":"Choudhary","year":"2021","journal-title":"J Travel Med"},{"key":"R21-20260417","doi-asserted-by":"crossref","first-page":"102550","DOI":"10.1016\/j.tmaid.2023.102550","article-title":"mRNA vaccines as an armor to combat the infectious diseases","volume":"52","author":"Priyanka","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"R22-20260417","doi-asserted-by":"crossref","first-page":"115597","DOI":"10.1016\/j.biopha.2023.115597","article-title":"Nanovaccines: a game changing approach in the fight against infectious diseases","volume":"167","author":"Abusalah","year":"2023","journal-title":"Biomed Pharmacothe"},{"key":"R23-20260417","doi-asserted-by":"crossref","first-page":"1961\u201370","DOI":"10.1016\/j.jiph.2023.09.020","article-title":"Exploring the structural and molecular interaction landscape of nirmatrelvir and Mpro complex: the study might assist in designing more potent antivirals targeting SARS-CoV-2 and other viruses","volume":"16","author":"Chakraborty","year":"2023","journal-title":"J Infect Public Health"},{"key":"R24-20260417","doi-asserted-by":"crossref","first-page":"e29007","DOI":"10.1002\/jmv.29007","article-title":"Azvudine therapy of common COVID-19 in hemodialysis patients","volume":"95","author":"Shang","year":"2023","journal-title":"J Med Virol"},{"key":"R25-20260417","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2014.12.FOCUS14748","article-title":"Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors","volume":"38","author":"Golden","year":"2015","journal-title":"Neurosurg Focus"},{"key":"R26-20260417","first-page":"43:170\u201372","article-title":"2019 \u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u6297\u75c5\u6bd2\u6cbb\u7597\u6709\u836f\u53ef\u671f","author":"\u674e\u8f89","year":"2020","journal-title":"\u4e2d\u534e\u7ed3\u6838\u548c\u547c\u5438\u6742\u5fd7"},{"key":"R27-20260417","doi-asserted-by":"crossref","first-page":"617\u201322","DOI":"10.1038\/s41586-021-04232-5","article-title":"A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity","volume":"601","author":"Heitmann","year":"2022","journal-title":"Nature"},{"key":"R28-20260417","first-page":"720","article-title":"Alterations in T and B cell function persist in convalescent COVID-19 patients","volume":"2","author":"Shuwa","year":"2021","journal-title":"Med (New York, NY)"},{"key":"R29-20260417","doi-asserted-by":"crossref","first-page":"116707","DOI":"10.1016\/j.diagmicrobio.2025.116707","article-title":"Exploring the dynamics of SARS-CoV-2 and HIV co-infection: mutation risks, therapeutic efficacy, and future variant prevention","volume":"111","author":"Maliha","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R30-20260417","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia","volume":"146","author":"Quinti","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R31-20260417","first-page":"411\u201317","article-title":"\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e(COVID-19)\u4e09\u4f8b\u9057\u4f53\u591a\u90e8\u4f4d\u7a7f\u523a\u7ec4\u7ec7\u75c5\u7406\u5b66\u7814\u7a76","volume":"49","author":"\u59da\u5c0f\u7ea2","year":"2020","journal-title":"%J \u4e2d\u534e\u75c5\u7406\u5b66\u6742\u5fd7"},{"key":"R32-20260417","first-page":"576\u201382","article-title":"\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\u75be\u75c5\u5341\u4f8b\u7a7f\u523a\u5c38\u68c0\u75c5\u4f8b\u813e\u810f\u75c5\u7406\u5b66\u6539\u53d8","volume":"49","author":"\u8bb8\u971e","year":"2020","journal-title":"%J \u4e2d\u534e\u75c5\u7406\u5b66\u6742\u5fd7"},{"key":"R33-20260417","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"R34-20260417","doi-asserted-by":"crossref","first-page":"ltab015","DOI":"10.1093\/immadv\/ltab015","article-title":"Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact","volume":"1","author":"Zhang","year":"2021","journal-title":"Immunother Adv"},{"key":"R35-20260417","article-title":"Study of the lymphocyte change between COVID-19 and non-COVID-19 pneumonia cases suggesting other factors besides uncontrolled inflammation contributed to multi-organ injury","author":"Zheng","year":"2020","journal-title":"SSRN Elec J"},{"key":"R36-20260417","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13073-022-01049-3","article-title":"Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19","volume":"14","author":"Guo","year":"2022","journal-title":"Genome Med"},{"key":"R37-20260417","doi-asserted-by":"crossref","first-page":"14\u201318","DOI":"10.1016\/j.immuni.2020.12.009","article-title":"T cell memory: understanding COVID-19","volume":"54","author":"Jarjour","year":"2021","journal-title":"Immunity"},{"key":"R38-20260417","doi-asserted-by":"crossref","first-page":"1449\u201351","DOI":"10.1080\/15548627.2024.2312787","article-title":"The role of SARS-CoV-2 ORF7a in autophagy flux disruption: implications for viral infection and pathogenesis","volume":"20","author":"Li","year":"2024","journal-title":"Autophagy"},{"key":"R39-20260417","doi-asserted-by":"crossref","first-page":"e29200","DOI":"10.1002\/jmv.29200","article-title":"SARS-CoV-2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis","volume":"95","author":"Li","year":"2023","journal-title":"J Med Virol"},{"key":"R40-20260417","doi-asserted-by":"crossref","first-page":"473\u201374","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"R41-20260417","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/s41591-020-01186-5","article-title":"Author correction: a dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nature Med"},{"key":"R42-20260417","doi-asserted-by":"crossref","first-page":"463\u201369","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"R43-20260417","doi-asserted-by":"crossref","first-page":"106939","DOI":"10.1016\/j.intimp.2020.106939","article-title":"Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment","volume":"88","author":"Li","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R44-20260417","doi-asserted-by":"crossref","first-page":"1052\u201362","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"key":"R45-20260417","doi-asserted-by":"crossref","first-page":"131\u201344","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"R46-20260417","doi-asserted-by":"crossref","first-page":"481\u201399","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"R47-20260417","doi-asserted-by":"crossref","first-page":"397\u2013408","DOI":"10.1634\/theoncologist.11-4-397","article-title":"TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility","volume":"11","author":"van Horssen","year":"2006","journal-title":"Oncologist"},{"key":"R48-20260417","doi-asserted-by":"crossref","first-page":"551\u201355","DOI":"10.1002\/bjs.1800830438","article-title":"Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat","volume":"83","author":"Manusama","year":"1996","journal-title":"Br J Surg"},{"key":"R49-20260417","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","article-title":"MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells","volume":"40","author":"Limagne","year":"2022","journal-title":"Cancer Cell"},{"key":"R50-20260417","doi-asserted-by":"crossref","first-page":"e13115","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Proliferation"},{"key":"R51-20260417","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.3390\/ijms21218412","article-title":"CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R52-20260417","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/biom11010091","article-title":"Cytokines and chemokines in SARS-CoV-2 infections-therapeutic strategies targeting cytokine storm","volume":"11","author":"Pum","year":"2021","journal-title":"Biomolecules"},{"key":"R53-20260417","doi-asserted-by":"crossref","first-page":"861\u201380","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"R54-20260417","first-page":"1031\u201338","article-title":"Interferon-alpha-induced apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent and -independent manner","volume":"18","author":"Yanase","year":"2007","journal-title":"Oncol Rep"},{"key":"R55-20260417","doi-asserted-by":"crossref","first-page":"872\u201379","DOI":"10.4161\/cbt.6.6.4088","article-title":"Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells","volume":"6","author":"Papageorgiou","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"R56-20260417","doi-asserted-by":"crossref","first-page":"1251\u201362","DOI":"10.1038\/sj.onc.1205179","article-title":"Mechanisms of interferon-alpha induced apoptosis in malignant cells","volume":"21","author":"Thyrell","year":"2002","journal-title":"Oncogene"},{"key":"R57-20260417","doi-asserted-by":"crossref","first-page":"872627","DOI":"10.3389\/fmed.2022.872627","article-title":"Coinfection of COVID-19 and dengue: a case report","volume":"9","author":"Prapty","year":"2022","journal-title":"Front Med"},{"key":"R58-20260417","doi-asserted-by":"crossref","first-page":"620\u201332","DOI":"10.3906\/sag-2004-168","article-title":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs","volume":"50","author":"Tufan","year":"2020","journal-title":"Turk J Med Sci"},{"key":"R59-20260417","doi-asserted-by":"crossref","first-page":"1400\u201309","DOI":"10.1093\/cid\/ciaa410","article-title":"Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the Pathogenesis of COVID-19","volume":"71","author":"Chu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R60-20260417","doi-asserted-by":"crossref","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"key":"R61-20260417","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"R62-20260417","doi-asserted-by":"crossref","first-page":"998\u20131002","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl Sci Rev"},{"key":"R63-20260417","first-page":"3037\u201346","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"R64-20260417","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1016\/S2665-9913(20)30340-4","article-title":"Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?","volume":"2","author":"Zizzo","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"R65-20260417","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmunity Rev"},{"key":"R66-20260417","doi-asserted-by":"crossref","first-page":"234\u201348","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R67-20260417","doi-asserted-by":"crossref","first-page":"e933973","DOI":"10.12659\/MSM.933973","article-title":"Editorial: tocilizumab, a humanized therapeutic IL-6 receptor (IL-6R) monoclonal antibody, and future combination therapies for severe COVID-19","volume":"27","author":"Parums","year":"2021","journal-title":"Med Sci Monit"},{"key":"R68-20260417","doi-asserted-by":"crossref","first-page":"409\u201316","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"R69-20260417","doi-asserted-by":"crossref","first-page":"6\u201315","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br J Cancer"},{"key":"R70-20260417","first-page":"1\u201318","article-title":"The dual role of tumor necrosis factor-alpha (TNF-\u03b1) in breast cancer: molecular insights and therapeutic approaches","volume":"43","author":"Cruceriu","year":"2020","journal-title":"Cell Oncol (Dordrecht, Netherlands)"},{"key":"R71-20260417","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-020-00237-0","article-title":"Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"R72-20260417","first-page":"1\u201327","article-title":"The diverse roles of the TNF axis in cancer progression and metastasis","volume":"11","author":"Ham","year":"2016","journal-title":"Trends Cancer Res"},{"key":"R73-20260417","doi-asserted-by":"crossref","first-page":"78\u201389","DOI":"10.1016\/j.cytogfr.2021.10.005","article-title":"Cancer and Covid-19: collectively catastrophic","volume":"63","author":"du Plessis","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"R74-20260417","doi-asserted-by":"crossref","first-page":"49\u201362","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R75-20260417","doi-asserted-by":"crossref","first-page":"452\u201355","DOI":"10.1097\/COC.0000000000000712","article-title":"The impact of the COVID-19 pandemic on cancer patients","volume":"43","author":"Al-Quteimat","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"R76-20260417","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3390\/vaccines10122145","article-title":"SARS-CoV-2: an updated review highlighting its evolution and treatments","volume":"10","author":"Zhang","year":"2022","journal-title":"Vaccines"},{"key":"R77-20260417","first-page":"13:5718","article-title":"Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients","author":"De Winter","year":"2021","journal-title":"Cancers"},{"key":"R78-20260417","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"R79-20260417","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/jcm12041630","article-title":"Present and (foreseeable) future of biological anti-TNF alpha therapy","volume":"12","author":"Leone","year":"2023","journal-title":"J Clin Med"},{"key":"R80-20260417","doi-asserted-by":"crossref","first-page":"3034\u201345","DOI":"10.2741\/2908","article-title":"TNF and manipulation of the tumor cell-stromal interface: \u201cways to make chemotherapy effective.\u201d","volume":"13","author":"Seynhaeve","year":"2008","journal-title":"Front Biosci"},{"key":"R81-20260417","doi-asserted-by":"crossref","first-page":"e002392","DOI":"10.1136\/jitc-2021-002392","article-title":"Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy","volume":"9","author":"Iovino","year":"2021","journal-title":"J Immunother Cancer"},{"key":"R82-20260417","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s13054-020-03328-0","article-title":"CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS","volume":"24","author":"Blot","year":"2020","journal-title":"Crit Care (London, England)"},{"key":"R83-20260417","first-page":"1067\u201368","article-title":"Chemokine\/chemokine receptor nomenclature","volume":"22","author":"Bacon","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"R85-20260417","doi-asserted-by":"crossref","first-page":"109504","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep"},{"key":"R86-20260417","doi-asserted-by":"crossref","first-page":"7175\u201387","DOI":"10.7150\/thno.59056","article-title":"CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors","volume":"11","author":"Shi","year":"2021","journal-title":"Theranostics"},{"key":"R87-20260417","doi-asserted-by":"crossref","first-page":"24\u201328","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"key":"R88-20260417","doi-asserted-by":"crossref","first-page":"40\u201347","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"R89-20260417","doi-asserted-by":"crossref","first-page":"487\u2013504","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R90-20260417","doi-asserted-by":"crossref","first-page":"899972","DOI":"10.3389\/fimmu.2022.899972","article-title":"Reduced antibodies and innate cytokine changes in SARS-CoV-2 BNT162b2 mRNA vaccinated transplant patients with hematological malignancies","volume":"13","author":"Bergamaschi","year":"2022","journal-title":"Front Immunol"},{"key":"R91-20260417","doi-asserted-by":"crossref","first-page":"1134\u201338","DOI":"10.6004\/jnccn.2022.7048","article-title":"Immune-related adverse events among COVID-19-vaccinated patients with cancer receiving immune checkpoint blockade","volume":"20","author":"Widman","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"R92-20260417","doi-asserted-by":"crossref","first-page":"357\u201360","DOI":"10.1016\/j.ajem.2021.01.067","article-title":"COVID-19 in patients with cancer: risks and precautions","volume":"48","author":"Razavi","year":"2021","journal-title":"Am J Emerg Med"},{"key":"R93-20260417","doi-asserted-by":"crossref","first-page":"1112\u201323","DOI":"10.1136\/gutjnl-2017-313738","article-title":"Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma","volume":"67","author":"Nywening","year":"2018","journal-title":"Gut"},{"key":"R94-20260417","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/healthcare10050825","article-title":"Impact of the COVID-19 pandemic on oncology patients\u2019 mental health and treatment plans","volume":"10","author":"Althumairi","year":"2022","journal-title":"Healthcare"},{"key":"R95-20260417","doi-asserted-by":"crossref","first-page":"61\u201386","DOI":"10.1016\/S1359-6101(99)00005-2","article-title":"The MCP\/eotaxin subfamily of CC chemokines","volume":"10","author":"Van Coillie","year":"1999","journal-title":"Cytokine Growth Factor Rev"},{"key":"R96-20260417","doi-asserted-by":"crossref","first-page":"105\u201318","DOI":"10.2174\/1871530315666150316120920","article-title":"CCL2-CCR2 signaling in disease pathogenesis","volume":"15","author":"O\u2019Connor","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R97-20260417","doi-asserted-by":"crossref","first-page":"497\u2013506","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"R98-20260417","doi-asserted-by":"crossref","first-page":"1833\u201341","DOI":"10.1172\/JCI200113116","article-title":"Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease","volume":"108","author":"Choi","year":"2001","journal-title":"J Clin Invest"},{"key":"R99-20260417","doi-asserted-by":"crossref","first-page":"2195\u2013202","DOI":"10.1182\/blood.V100.6.2195","article-title":"Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma","volume":"100","author":"Abe","year":"2002","journal-title":"Blood"},{"key":"R100-20260417","doi-asserted-by":"crossref","first-page":"3778\u201383","DOI":"10.1182\/blood-2002-08-2641","article-title":"AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma","volume":"101","author":"Choi","year":"2003","journal-title":"Blood"},{"key":"R101-20260417","doi-asserted-by":"crossref","first-page":"4258\u201371","DOI":"10.1002\/jcp.26245","article-title":"The MIP-1\u03b1 autocrine loop contributes to decreased sensitivity to anticancer drugs","volume":"233","author":"Tsubaki","year":"2018","journal-title":"J Cell Physiol"},{"key":"R102-20260417","doi-asserted-by":"crossref","first-page":"e21402","DOI":"10.1096\/fj.202000938RR","article-title":"Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling","volume":"35","author":"Ackun-Farmmer","year":"2021","journal-title":"FASEB J"},{"key":"R103-20260417","doi-asserted-by":"crossref","first-page":"270\u201374","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"R104-20260417","doi-asserted-by":"crossref","first-page":"635\u201347","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4(+) T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"R105-20260417","doi-asserted-by":"crossref","first-page":"6075\u201382","DOI":"10.1158\/1078-0432.CCR-21-0697","article-title":"Role of B cells in responses to checkpoint blockade immunotherapy and overall survival of cancer patients","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"key":"R106-20260417","doi-asserted-by":"crossref","first-page":"200\u201318","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"R107-20260417","doi-asserted-by":"crossref","first-page":"669474","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and Regulation of T(H) Cells: a Balancing Act for Cancer Immunotherapy","volume":"12","author":"Basu","year":"2021","journal-title":"Front Immunol"},{"key":"R108-20260417","doi-asserted-by":"crossref","first-page":"188762","DOI":"10.1016\/j.bbcan.2022.188762","article-title":"Tumor-associated neutrophils and neutrophil-targeted cancer therapies","volume":"1877","author":"Que","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R109-20260417","first-page":"173\u201385","article-title":"3D tissue culture model for virology studies","volume":"2940","author":"Li","year":"2025","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"key":"R110-20260417","doi-asserted-by":"crossref","first-page":"616","DOI":"10.18063\/ijb.v8i4.616","article-title":"3D bioprinting for regenerating COVID-19-mediated irreversibly damaged lung tissue","volume":"8","author":"Akter","year":"2022","journal-title":"Int J Bioprinting"},{"key":"R111-20260417","doi-asserted-by":"crossref","first-page":"1925\u201334","DOI":"10.1007\/s11033-021-06149-8","article-title":"SARS-COV-2 infection and lung tumor microenvironment","volume":"48","author":"Malkani","year":"2021","journal-title":"Mol Biol Rep"},{"key":"R112-20260417","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"R113-20260417","doi-asserted-by":"crossref","first-page":"122\u201329","DOI":"10.3201\/2701.203772","article-title":"Cellular immunity in COVID-19 convalescents with PCR-confirmed infection but with undetectable SARS-CoV-2-specific IgG","volume":"27","author":"Schwarzkopf","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R114-20260417","doi-asserted-by":"crossref","first-page":"78\u201385","DOI":"10.1038\/s41591-020-01143-2","article-title":"Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells","volume":"27","author":"Schulien","year":"2021","journal-title":"Nature Med"},{"key":"R115-20260417","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"R116-20260417","doi-asserted-by":"crossref","first-page":"5490\u2013500","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"R117-20260417","doi-asserted-by":"crossref","first-page":"363\u201374","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R118-20260417","doi-asserted-by":"crossref","first-page":"718\u201338","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8(+) T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"R119-20260417","doi-asserted-by":"crossref","first-page":"136020","DOI":"10.1016\/j.ijbiomac.2024.136020","article-title":"SARS-CoV-2 S protein harbors furin cleavage site located in a short loop between antiparallel \u03b2-strand","volume":"281","author":"Bashir","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"R120-20260417","doi-asserted-by":"crossref","first-page":"904\u201316","DOI":"10.1038\/s41591-021-01329-2","article-title":"Single-cell multi-omics analysis of the immune response in COVID-19","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nature Med"},{"key":"R121-20260417","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"R122-20260417","doi-asserted-by":"crossref","first-page":"1280\u201389","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nature Med"},{"key":"R123-20260417","doi-asserted-by":"crossref","first-page":"594\u201399","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"R124-20260417","doi-asserted-by":"crossref","first-page":"2900\u201308","DOI":"10.4049\/jimmunol.2100068","article-title":"Metabolic defects of peripheral T cells in COVID-19 patients","volume":"206","author":"Liu","year":"2021","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"R125-20260417","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","article-title":"Imbalance of regulatory and cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19","volume":"183","author":"Meckiff","year":"2020","journal-title":"Cell"},{"key":"R126-20260417","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","article-title":"Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19","volume":"183","author":"Su","year":"2020","journal-title":"Cell"},{"key":"R127-20260417","doi-asserted-by":"crossref","first-page":"1132\u201348","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"R128-20260417","doi-asserted-by":"crossref","first-page":"e004371","DOI":"10.1136\/jitc-2021-004371","article-title":"Spontaneous tumor regression following COVID-19 vaccination","volume":"10","author":"Sousa","year":"2022","journal-title":"J Immunother Cancer"},{"key":"R129-20260417","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12967-023-04110-w","article-title":"Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment","volume":"21","author":"Meo","year":"2023","journal-title":"J Transl Med"},{"key":"R130-20260417","doi-asserted-by":"crossref","first-page":"e29113","DOI":"10.1002\/jmv.29113","article-title":"The binding profile of SARS-CoV-2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion","volume":"95","author":"Zhan","year":"2023","journal-title":"J Med Virol"},{"key":"R131-20260417","doi-asserted-by":"crossref","first-page":"772\u201376","DOI":"10.1002\/cyto.a.24172","article-title":"Lymphocyte subset counts in COVID-19 patients: a meta-analysis","volume":"97","author":"Huang","year":"2020","journal-title":"Cytometry A"},{"key":"R132-20260417","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3390\/v13050767","article-title":"The significance of phenotyping and quantification of plasma extracellular vesicles levels using high-sensitivity flow cytometry during COVID-19 treatment","volume":"13","author":"Kudryavtsev","year":"2021","journal-title":"Viruses"},{"key":"R133-20260417","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/v14051082","article-title":"Dysregulated immune responses in SARS-CoV-2-infected patients: a comprehensive overview","volume":"14","author":"Kudryavtsev","year":"2022","journal-title":"Viruses"},{"key":"R134-20260417","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","article-title":"Loss of Bcl-6-expressing t follicular helper cells and germinal centers in COVID-19","volume":"183","author":"Kaneko","year":"2020","journal-title":"Cell"},{"key":"R135-20260417","doi-asserted-by":"crossref","first-page":"1506\u201316","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"key":"R136-20260417","doi-asserted-by":"crossref","first-page":"970\u201373","DOI":"10.1007\/s10875-020-00806-6","article-title":"Flow cytometry identifies risk factors and dynamic changes in patients with COVID-19","volume":"40","author":"Moratto","year":"2020","journal-title":"J Clin Immunol"},{"key":"R137-20260417","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/v13101966","article-title":"Imbalanced immune response of T-cell and B-cell subsets in patients with moderate and severe COVID-19","volume":"13","author":"Golovkin","year":"2021","journal-title":"Viruses"},{"key":"R138-20260417","doi-asserted-by":"crossref","first-page":"194\u2013205","DOI":"10.3390\/cimb44010014","article-title":"Alterations in B cell and follicular t-helper cell subsets in patients with acute COVID-19 and COVID-19 convalescents","volume":"44","author":"Kudryavtsev","year":"2021","journal-title":"Curr Issues Mol Biol"},{"key":"R139-20260417","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"R140-20260417","doi-asserted-by":"crossref","first-page":"17718","DOI":"10.1038\/s41598-020-73955-8","article-title":"Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"R141-20260417","doi-asserted-by":"crossref","first-page":"461\u201369","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"R142-20260417","doi-asserted-by":"crossref","first-page":"629\u201341","DOI":"10.1002\/JLB.6RI0917-390R","article-title":"Diversification of human NK cells: lessons from deep profiling","volume":"103","author":"Wilk","year":"2018","journal-title":"J Leukoc Biol"},{"key":"R143-20260417","first-page":"m1192","article-title":"Don\u2019t forget chronic lung and immune conditions during covid-19, says WHO","volume":"368","author":"Thornton","year":"2020","journal-title":"BMJ (Clinical Research Ed)"},{"key":"R144-20260417","doi-asserted-by":"crossref","first-page":"1391\u2013405","DOI":"10.1007\/s40121-021-00458-y","article-title":"Dynamic changes in the immune response correlate with disease severity and outcomes during infection with SARS-CoV-2","volume":"10","author":"Zheng","year":"2021","journal-title":"Infect Dis Ther"},{"key":"R145-20260417","doi-asserted-by":"crossref","first-page":"1589\u201398","DOI":"10.1002\/jmv.26505","article-title":"Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: clinical and laboratory characteristics","volume":"93","author":"Taghiloo","year":"2021","journal-title":"J Med Virol"},{"key":"R146-20260417","doi-asserted-by":"crossref","first-page":"108524","DOI":"10.1016\/j.clim.2020.108524","article-title":"Long-term infection of SARS-CoV-2 changed the body\u2019s immune status","volume":"218","author":"Lin","year":"2020","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"R147-20260417","doi-asserted-by":"crossref","first-page":"1762\u201369","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J Infect Dis"},{"key":"R148-20260417","doi-asserted-by":"crossref","first-page":"108943","DOI":"10.1016\/j.celrep.2021.108943","article-title":"Cell-type-specific immune dysregulation in severely ill COVID-19 patients","volume":"34","author":"Yao","year":"2021","journal-title":"Cell Rep"},{"key":"R149-20260417","doi-asserted-by":"crossref","first-page":"659018","DOI":"10.3389\/fimmu.2021.659018","article-title":"Immunological biomarkers of fatal COVID-19: a study of 868 patients","volume":"12","author":"Mart\u00edn-S\u00e1nchez","year":"2021","journal-title":"Front Immunol"},{"key":"R150-20260417","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.3390\/cells10113182","article-title":"NK and T cell immunological signatures in hospitalized patients with COVID-19","volume":"10","author":"Bergantini","year":"2021","journal-title":"Cells"},{"key":"R151-20260417","doi-asserted-by":"crossref","first-page":"995\u201397","DOI":"10.1038\/s41423-020-0493-9","article-title":"Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19","volume":"17","author":"Demaria","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"R152-20260417","doi-asserted-by":"crossref","first-page":"533\u201335","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"R153-20260417","doi-asserted-by":"crossref","first-page":"842\u201344","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nature Med"},{"key":"R154-20260417","doi-asserted-by":"crossref","first-page":"eabd6832","DOI":"10.1126\/sciimmunol.abd6832","article-title":"Natural killer cell immunotypes related to COVID-19 disease severity","volume":"5","author":"Maucourant","year":"2020","journal-title":"Sci Immunol"},{"key":"R155-20260417","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.3390\/ijms21176351","article-title":"Natural killer cell dysfunction and its role in COVID-19","volume":"21","author":"van Eeden","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R156-20260417","doi-asserted-by":"crossref","first-page":"127\u201329","DOI":"10.1038\/s41423-021-00825-2","article-title":"NK cell dysfunction in patients with COVID-19","volume":"19","author":"Bi","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"R157-20260417","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3390\/ijms23063374","article-title":"CD8(+) T cell senescence: lights and shadows in viral infections, autoimmune disorders and cancer","volume":"23","author":"Tedeschi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R158-20260417","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R159-20260417","doi-asserted-by":"crossref","first-page":"408\u201316","DOI":"10.1016\/j.pnpbp.2017.07.023","article-title":"The role of Th17 cells in auto-inflammatory neurological disorders","volume":"79","author":"Tahmasebinia","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R160-20260417","doi-asserted-by":"crossref","first-page":"e002266","DOI":"10.1136\/jitc-2020-002266","article-title":"Severity of COVID-19 in patients with lung cancer: evidence and challenges","volume":"9","author":"Passaro","year":"2021","journal-title":"J Immunother Cancer"},{"key":"R161-20260417","doi-asserted-by":"crossref","first-page":"1263\u201371","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res"},{"key":"R162-20260417","doi-asserted-by":"crossref","first-page":"3788\u201399","DOI":"10.1158\/0008-5472.CAN-15-0054","article-title":"IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment","volume":"75","author":"Benevides","year":"2015","journal-title":"Cancer Res"},{"key":"R163-20260417","doi-asserted-by":"crossref","first-page":"1061\u201367","DOI":"10.1038\/sj.bjc.6604963","article-title":"The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer","volume":"100","author":"Horlock","year":"2009","journal-title":"Br J Cancer"},{"key":"R164-20260417","doi-asserted-by":"crossref","first-page":"216\u201324","DOI":"10.1002\/eji.200838475","article-title":"Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells","volume":"39","author":"Martin-Orozco","year":"2009","journal-title":"Eur J Immunol"},{"key":"R165-20260417","doi-asserted-by":"crossref","first-page":"1141\u201349","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"R166-20260417","doi-asserted-by":"crossref","first-page":"368\u201370","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"R167-20260417","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/cells10061550","article-title":"The role of Th17 response in COVID-19","volume":"10","author":"Martonik","year":"2021","journal-title":"Cells"},{"key":"R168-20260417","doi-asserted-by":"crossref","first-page":"169\u201380","DOI":"10.1016\/j.chom.2013.01.005","article-title":"Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps","volume":"13","author":"Jenne","year":"2013","journal-title":"Cell Host Microbe"},{"key":"R169-20260417","doi-asserted-by":"crossref","first-page":"14355\u201361","DOI":"10.1007\/s13277-016-5328-z","article-title":"NETs in cancer","volume":"37","author":"Garley","year":"2016","journal-title":"Tumour Biol"},{"key":"R170-20260417","first-page":"63\u201373","article-title":"Evidence and impact of neutrophil extracellular traps in malignant melanoma","volume":"33","author":"Schedel","year":"2020","journal-title":"Pigm Cell Mel Res"},{"key":"R171-20260417","doi-asserted-by":"crossref","first-page":"15\u201328","DOI":"10.1016\/j.immuni.2016.12.012","article-title":"Neutrophils in homeostasis, immunity, and cancer","volume":"46","author":"Nicol\u00e1s-\u00c1vila","year":"2017","journal-title":"Immunity"},{"key":"R172-20260417","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s13054-018-2290-8","article-title":"Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia","volume":"22","author":"Mikacenic","year":"2018","journal-title":"Crit Care (London, England)"},{"key":"R173-20260417","doi-asserted-by":"crossref","first-page":"428\u201337","DOI":"10.1093\/infdis\/jix475","article-title":"High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza a infection","volume":"217","author":"Zhu","year":"2018","journal-title":"J Infect Dis"},{"key":"R174-20260417","first-page":"e138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"R175-20260417","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"key":"R176-20260417","doi-asserted-by":"crossref","first-page":"154\u201367","DOI":"10.1111\/apt.16717","article-title":"Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments","volume":"55","author":"Kokkotis","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"R177-20260417","doi-asserted-by":"crossref","first-page":"5358\u201366","DOI":"10.4049\/jimmunol.163.10.5358","article-title":"Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells","volume":"163","author":"Kashii","year":"1999","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"R178-20260417","doi-asserted-by":"crossref","first-page":"3645\u201351","DOI":"10.4049\/jimmunol.164.7.3645","article-title":"Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 lewis lung carcinoma cells in vivo","volume":"164","author":"Pr\u00e9vost-Blondel","year":"2000","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"R179-20260417","doi-asserted-by":"crossref","first-page":"1067\u201385","DOI":"10.1084\/jem.167.3.1067","article-title":"The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity","volume":"167","author":"Havell","year":"1988","journal-title":"J Exp Med"},{"key":"R180-20260417","doi-asserted-by":"crossref","first-page":"361\u201371","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R181-20260417","doi-asserted-by":"crossref","first-page":"121\u201326","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann Afr Med"},{"key":"R182-20260417","doi-asserted-by":"crossref","first-page":"70\u201380","DOI":"10.1016\/j.ejca.2020.08.013","article-title":"Immunological features of coronavirus disease 2019 in patients with cancer","volume":"139","author":"Thibaudin","year":"2020","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"R183-20260417","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","article-title":"Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity","volume":"39","author":"Chow","year":"2021","journal-title":"Cancer Cell"},{"key":"R184-20260417","doi-asserted-by":"crossref","first-page":"2904\u201317","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res"},{"key":"R185-20260417","first-page":"186\u201392","article-title":"Impact of COVID-19 on cancer patients: a review","volume":"17","author":"Cavalcanti","year":"2021","journal-title":"Asia-Pac J Clini Oncol"},{"key":"R186-20260417","doi-asserted-by":"crossref","first-page":"864298","DOI":"10.3389\/fimmu.2022.864298","article-title":"CD8(+) T cells in SARS-CoV-2 induced disease and cancer-clinical perspectives","volume":"13","author":"Mortezaee","year":"2022","journal-title":"Front Immunol"},{"key":"R187-20260417","doi-asserted-by":"crossref","first-page":"1901\u201311","DOI":"10.4049\/jimmunol.2100629","article-title":"IFITM3 is upregulated characteristically in IL-15-mediated bystander-activated CD8(+) T cells during influenza infection","volume":"208","author":"Jeong","year":"2022","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"R188-20260417","doi-asserted-by":"crossref","first-page":"e28487","DOI":"10.1002\/jmv.28487","article-title":"How does SARS-CoV-2 infection impact on immunity, procession and treatment of pan cancers","volume":"95","author":"Xiong","year":"2023","journal-title":"J Med Virol"},{"key":"R189-20260417","doi-asserted-by":"crossref","first-page":"1854424","DOI":"10.1080\/2162402X.2020.1854424","article-title":"Immunological alternation in COVID-19 patients with cancer and its implications on mortality","volume":"10","author":"Cai","year":"2021","journal-title":"Oncoimmunology"},{"key":"R190-20260417","doi-asserted-by":"crossref","first-page":"978760","DOI":"10.3389\/fimmu.2022.978760","article-title":"Case report: understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity","volume":"13","author":"Lau","year":"2022","journal-title":"Front Immunol"},{"key":"R191-20260417","doi-asserted-by":"crossref","first-page":"221\u201328","DOI":"10.1046\/j.1365-3083.2002.01053.x","article-title":"NK cells, MHC class I molecules and the missing self","volume":"55","author":"K\u00e4rre","year":"2002","journal-title":"Scand J Immunol"},{"key":"R192-20260417","doi-asserted-by":"crossref","first-page":"11991\u201399","DOI":"10.1158\/0008-5472.CAN-07-2068","article-title":"Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2","volume":"67","author":"Varchetta","year":"2007","journal-title":"Cancer Res"},{"key":"R193-20260417","doi-asserted-by":"crossref","first-page":"3940\u201347","DOI":"10.1200\/JCO.2003.05.013","article-title":"Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma","volume":"21","author":"Weng","year":"2003","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R194-20260417","doi-asserted-by":"crossref","first-page":"1628\u201338","DOI":"10.1038\/s41590-023-01560-8","article-title":"Defining the role of natural killer cells in COVID-19","volume":"24","author":"Lee","year":"2023","journal-title":"Nat Immunol"},{"key":"R195-20260417","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.immuni.2021.09.002","article-title":"Early IFN-\u03b1 signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19","volume":"54","author":"Kr\u00e4mer","year":"2021","journal-title":"Immunity"},{"key":"R196-20260417","doi-asserted-by":"crossref","first-page":"604\u201312","DOI":"10.1038\/s41423-020-00557-9","article-title":"Unique immunological profile in patients with COVID-19","volume":"18","author":"Varchetta","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R197-20260417","doi-asserted-by":"crossref","first-page":"507\u201313","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet (London, England)"},{"key":"R198-20260417","doi-asserted-by":"crossref","first-page":"110503","DOI":"10.1016\/j.celrep.2022.110503","article-title":"SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells","volume":"38","author":"Hammer","year":"2022","journal-title":"Cell Rep"},{"key":"R199-20260417","doi-asserted-by":"crossref","first-page":"833967","DOI":"10.3389\/fpubh.2022.833967","article-title":"Targeting TNF-\u03b1 for COVID-19: recent advanced and controversies","volume":"10","author":"Guo","year":"2022","journal-title":"Front Public Health"},{"key":"R200-20260417","doi-asserted-by":"crossref","first-page":"758\u201367","DOI":"10.1080\/15548627.2022.2099206","article-title":"Neutrophil autophagy and NETosis in COVID-19: perspectives","volume":"19","author":"Zhang","year":"2023","journal-title":"Autophagy"},{"key":"R201-20260417","doi-asserted-by":"crossref","first-page":"e07635","DOI":"10.1016\/j.heliyon.2021.e07635","article-title":"Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19","volume":"7","author":"Jeyaraman","year":"2021","journal-title":"Heliyon"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:03:38Z","timestamp":1776423818000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":198,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004053","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"2025-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}